Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Search research articles

Related Experiment Videos

Lithium therapy in aggressive mentally subnormal patients

The British Journal of Psychiatry : the Journal of Mental Science

|November 1, 1980

Summary

This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Self injury and mental handicap.

British medical journal (Clinical research ed.)·1987

See all related articles

Lithium carbonate showed significant improvement in aggressive behavior for mentally subnormal patients. While generally safe, one patient experienced tardive dyskinesia, necessitating treatment discontinuation.

Area of Science:

Psychiatry
Neuropharmacology

Background:

Aggressive behavior in mentally subnormal individuals presents significant clinical challenges.
Exploring effective pharmacological interventions for managing aggression is crucial.

Observation:

Fifteen aggressive mentally subnormal patients were treated with lithium carbonate.
Clinical observation and retrospective analysis of daily ward reports were used to assess response.

Findings:

Eleven out of fifteen patients demonstrated improvement in aggressive behavior.
Three patients showed no change, and one patient's aggression worsened.
One patient developed tardive dyskinesia, leading to treatment cessation; other side effects were minimal.

Implications:

Related Experiment Videos

Lithium carbonate may be an effective treatment for aggression in select mentally subnormal patients.
Careful monitoring for side effects, particularly tardive dyskinesia, is essential.
Further research into personalized lithium therapy for aggressive behavior is warranted.